Skip to main content

Professor advancing first inhaled antibody treatment for RSV  

February 26, 2024

Respiratory syncytial virus (RSV) causes lower respiratory tract infection in millions each year and is the leading cause of hospitalization in young children. It is also responsible for over a hundred thousand hospitalizations each year among the immunocompromised and the … Read more

Carolina scientists testing contraception that stops sperm in its tracks

August 11, 2021

University of North Carolina Eshelman School of Pharmacy has developed a panel of ultrapotent sperm-binding monoclonal antibodies as option for affordable, non-hormonal female contraception Scientists at the University of North Carolina at Chapel Hill are engineering molecularly tuned monoclonal antibodies … Read more

NC TraCS announces COVID-19 awards

June 10, 2020

The NC TraCS Institute announced pilot grant awards to researchers focused on COVID-19. In total, 34 applications were received and eight were chosen for funding. Awardees include investigators from UNC’s Eshelman School of Pharmacy, Gillings School of Global Public Health, … Read more